- Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com -
MISSISSAUGA, ON, March 23, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Nuvo's President & Chief Executive Officer and Kelly Demerino, Nuvo's Interim Chief Financial Officer will present live at LifeSciencesInvestorForum.com on March 26th.
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
About Nuvo Pharmaceuticals Inc. Nuvo (TSX: NRI; OTCQX: NRIFF) is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy and dermatology. The Company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Nuvo's head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the U.S. Food and Drug Administration (FDA), Health Canada and E.U. approved manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.nuvopharmaceuticals.com.
About Life Sciences Investor Forum Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet and present directly with investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is part of Intrado's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
About Intrado Intrado, formerly West, is an innovative, cloud-based, global technology partner to clients around the world. Our solutions connect people and organizations at the right time and in the right ways, making those mission-critical connections more relevant, engaging, and actionable—turning Information to Insight.
SOURCE Nuvo Pharmaceuticals Inc.
For further information: Nuvo Pharmaceuticals Inc., Investor Relations, Email: [email protected]; Life Sciences Investor Forum, John M. Viglotti, SVP Corporate Services, Investor Access, (212) 220-2221, [email protected]
Nuvo Pharmaceuticals Inc. (TSX:NRI; OTCQX:NRIFF) d/b/a Miravo Healthcare (Miravo or the Company) is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas,...